KMB

Kimberly-Clark
D

KMB

Arincen66/100B

Kimberly-Clark return on equity (ROE)

Kimberly-Clark's return on equity is 108.49%: net income of 3.34B USD over the last twelve months on shareholders' equity of 3.07B USD.

Today
108.49%
Average, 5 years
233.91%
Low, 5 years
108.49%
High, 5 years
412.59%

ROE (return on equity) = net income (last 12 months) ÷ shareholders' equity = 3.34B ÷ 3.07B = 108.49%

ROE (return on equity)
Net income
Shareholders' equity

Each quarter's net income over its last four quarters, over the shareholders' equity at the quarter end.

Why is Kimberly-Clark's return on equity so high?

Net margin
11.7%
profit on each dollar of sales
Asset turnover
1.00×
sales on each dollar of assets
Equity multiplier
11.47×
assets on each dollar of equity
Return on equity
134.6%
FY2025
  • FY202511.7% × 1.00 × 11.47 = 134.6%
  • FY202412.7% × 1.21 × 19.70 = 303.0%
  • FY20238.6% × 1.18 × 18.96 = 192.8%
  • FY20229.6% × 1.12 × 32.85 = 353.6%
  • FY20219.3% × 1.09 × 34.70 = 352.9%

The DuPont breakdown, on each year-end's assets and equity, as the return on equity elsewhere on this page. A high equity multiplier means a small equity base: debt, or buybacks that return the equity to shareholders, lift the return on what is left.

ROE (return on equity) by year and by quarter

Fiscal yearPeriod endingROE (return on equity)Net incomeShareholders' equity
Today108.49%3.34B3.07B
FY202531 Dec 2025136.42%2.05B1.50B
FY202431 Dec 2024306.90%2.58B840.00M
FY202331 Dec 2023192.79%1.76B915.00M
FY202231 Dec 2022358.50%1.96B547.00M
FY202131 Dec 2021358.75%1.84B514.00M
FY202031 Dec 2020382.75%2.40B626.00M
FY201931 Dec 2019—2.20B-33.00M
FY201831 Dec 2018—1.41B-287.00M
FY201731 Dec 2017362.16%2.28B629.00M
FY201631 Dec 2016—2.17B-102.00M
FY201531 Dec 2015—1.01B-174.00M
FY201431 Dec 2014209.33%1.53B729.00M
FY201331 Dec 201344.11%2.14B4.86B
FY201231 Dec 201233.10%1.75B5.29B
FY201131 Dec 201128.78%1.59B5.53B
FY201031 Dec 201029.72%1.84B6.20B
FY200931 Dec 200934.85%1.88B5.41B
FY200831 Dec 200843.58%1.69B3.88B
FY200731 Dec 200734.90%1.82B5.22B
FY200631 Dec 200624.59%1.50B6.10B
FY200531 Dec 200528.22%1.57B5.56B
FY200431 Dec 200427.15%1.80B6.63B
FY200331 Dec 200325.04%1.69B6.77B
FY200231 Dec 200229.64%1.67B5.65B
FY200131 Dec 200128.51%1.61B5.65B
FY200031 Dec 200031.22%1.80B5.77B
FY199931 Dec 199932.75%1.67B5.09B
FY199831 Dec 199829.99%1.17B3.89B
FY199731 Dec 199721.85%901.50M4.13B
FY199631 Dec 199631.31%1.40B4.48B
FY199531 Dec 19950.91%33.20M3.65B
FY199431 Dec 199420.61%535.10M2.60B
FY199331 Dec 199320.79%510.90M2.46B
FY199231 Dec 19926.16%135.00M2.19B
FY199131 Dec 199120.17%508.30M2.52B
FY199031 Dec 199019.12%432.10M2.26B
FY198931 Dec 198920.32%423.80M2.09B
FY198831 Dec 198820.29%378.60M1.87B
FY198731 Dec 198720.69%325.20M1.57B
FY198631 Dec 198614.03%269.40M1.92B
FY198531 Dec 198515.32%267.10M1.74B

Figures in USD. A quarter's revenue, net income and dividends are those of its last four quarters.

See also:P/E ratio,Market cap,P/S ratio,Dividend yield,Debt to equity,Current ratio,All ratios

Common questions about Kimberly-Clark's ROE

Source: Financial Modeling Prep

Risk Disclosure: Trading in financial instruments involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks. Never invest money you cannot afford to lose, and carefully assess the suitability of complex products such as CFDs and derivatives in light of your financial situation. Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed. Arincen would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes.

Arincen and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website. It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Arincen and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website. Arincen may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.

© 2026 - Arincen L.L.C-FZ - License No. 2420098.01. All Rights Reserved.